HB Ad Slot
HB Mobile Ad Slot
COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements [PODCAST]
by: Kenneth M. Kennedy of K&L Gates LLP  -  K&L Gates Triage
Thursday, November 12, 2020

In this week’s episode, Kenneth Kennedy discusses FDA’s ongoing focus on the issuance of warning letters to firms marketing fraudulent COVID-19 products, and to manufacturers who have failed to meet certain requirements under applicable FDA Emergency Use Authorizations (EUAs), as well as what manufacturers and health care providers alike can learn from this trend.

HB Ad Slot
HB Ad Slot
HB Mobile Ad Slot
HB Ad Slot
HB Mobile Ad Slot
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins